The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia

S. Faderl, Z. Estrov, Hm Kantarjian, D. Thomas, J. Cortes, T. Manshouri, C. C. Chan, K. J. Hays, S. Pierce, M. Albitar

Research output: Contribution to journalArticle

Abstract

Cytogenetic changes are of pivotal prognostic significance in patients with de novo acute lymphoblastic leukemia (ALL). However, in some cases leukemic blasts can harbor gene lesions on a submicroscopic level without evidence of a corresponding abnormality by conventional cytogenetic studies. This can result in failure to recognize chromosomal abnormalities and inappropriate evaluation with respect to therapy assignments. To study the discrepancy in the detection of deletions of the short arm of chromosome 9 and deletions of tumor suppressor genes p15/p16/p14 on chromosome 9p21, we analyzed bone marrow samples from 92 patients with ALL both by cytogenetic analysis and by Southern blot. In 41 patients (45%), we found deletions of p15/p16/p14, which were homozygous in 27 and hemizygous in 14. Cytogenetic analysis demonstrated abnormalities of the short arm of chromosome 9 in the form of 9p- or del(9p21-22) in only 5 of the 41 patients (12%). Only 2 of 51 patients without gene deletions as detected by Southern blot revealed a 9p- abnormality, which was found only in a subpopulation of the cells. We demonstrate that deletions of the p15/p16/p14 genes on chromosome 9p21 are more frequent than indicated by cytogenetic analysis. Molecular techniques in addition to cytogenetic studies are necessary to detect otherwise-unrecognized genetic lesions of the short arm of chromosome 9.

Original languageEnglish (US)
Pages (from-to)159-163
Number of pages5
JournalCytokines, Cellular and Molecular Therapy
Volume5
Issue number3
StatePublished - Sep 1 1999
Externally publishedYes

Fingerprint

Tumor Suppressor Protein p14ARF
Chromosome Deletion
Tumor Suppressor Genes
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Chromosome Aberrations
Chromosomes, Human, Pair 9
Cytogenetic Analysis
Incidence
Southern Blotting
Cytogenetics
Chromosomes
p16 Genes
Gene Deletion
Bone Marrow
Genes

Keywords

  • 9p21
  • Acute lymphoblastic leukemia
  • Cryptic abnormalities
  • Cytogenetics
  • Molecular abnormalities
  • p15/p16/p14 deletion

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia. / Faderl, S.; Estrov, Z.; Kantarjian, Hm; Thomas, D.; Cortes, J.; Manshouri, T.; Chan, C. C.; Hays, K. J.; Pierce, S.; Albitar, M.

In: Cytokines, Cellular and Molecular Therapy, Vol. 5, No. 3, 01.09.1999, p. 159-163.

Research output: Contribution to journalArticle

Faderl, S, Estrov, Z, Kantarjian, H, Thomas, D, Cortes, J, Manshouri, T, Chan, CC, Hays, KJ, Pierce, S & Albitar, M 1999, 'The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia', Cytokines, Cellular and Molecular Therapy, vol. 5, no. 3, pp. 159-163.
Faderl, S. ; Estrov, Z. ; Kantarjian, Hm ; Thomas, D. ; Cortes, J. ; Manshouri, T. ; Chan, C. C. ; Hays, K. J. ; Pierce, S. ; Albitar, M. / The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia. In: Cytokines, Cellular and Molecular Therapy. 1999 ; Vol. 5, No. 3. pp. 159-163.
@article{92ee6e08c30f43e5b127d569e11a62cc,
title = "The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia",
abstract = "Cytogenetic changes are of pivotal prognostic significance in patients with de novo acute lymphoblastic leukemia (ALL). However, in some cases leukemic blasts can harbor gene lesions on a submicroscopic level without evidence of a corresponding abnormality by conventional cytogenetic studies. This can result in failure to recognize chromosomal abnormalities and inappropriate evaluation with respect to therapy assignments. To study the discrepancy in the detection of deletions of the short arm of chromosome 9 and deletions of tumor suppressor genes p15/p16/p14 on chromosome 9p21, we analyzed bone marrow samples from 92 patients with ALL both by cytogenetic analysis and by Southern blot. In 41 patients (45{\%}), we found deletions of p15/p16/p14, which were homozygous in 27 and hemizygous in 14. Cytogenetic analysis demonstrated abnormalities of the short arm of chromosome 9 in the form of 9p- or del(9p21-22) in only 5 of the 41 patients (12{\%}). Only 2 of 51 patients without gene deletions as detected by Southern blot revealed a 9p- abnormality, which was found only in a subpopulation of the cells. We demonstrate that deletions of the p15/p16/p14 genes on chromosome 9p21 are more frequent than indicated by cytogenetic analysis. Molecular techniques in addition to cytogenetic studies are necessary to detect otherwise-unrecognized genetic lesions of the short arm of chromosome 9.",
keywords = "9p21, Acute lymphoblastic leukemia, Cryptic abnormalities, Cytogenetics, Molecular abnormalities, p15/p16/p14 deletion",
author = "S. Faderl and Z. Estrov and Hm Kantarjian and D. Thomas and J. Cortes and T. Manshouri and Chan, {C. C.} and Hays, {K. J.} and S. Pierce and M. Albitar",
year = "1999",
month = "9",
day = "1",
language = "English (US)",
volume = "5",
pages = "159--163",
journal = "Cytokines, Cellular and Molecular Therapy",
issn = "1368-4736",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia

AU - Faderl, S.

AU - Estrov, Z.

AU - Kantarjian, Hm

AU - Thomas, D.

AU - Cortes, J.

AU - Manshouri, T.

AU - Chan, C. C.

AU - Hays, K. J.

AU - Pierce, S.

AU - Albitar, M.

PY - 1999/9/1

Y1 - 1999/9/1

N2 - Cytogenetic changes are of pivotal prognostic significance in patients with de novo acute lymphoblastic leukemia (ALL). However, in some cases leukemic blasts can harbor gene lesions on a submicroscopic level without evidence of a corresponding abnormality by conventional cytogenetic studies. This can result in failure to recognize chromosomal abnormalities and inappropriate evaluation with respect to therapy assignments. To study the discrepancy in the detection of deletions of the short arm of chromosome 9 and deletions of tumor suppressor genes p15/p16/p14 on chromosome 9p21, we analyzed bone marrow samples from 92 patients with ALL both by cytogenetic analysis and by Southern blot. In 41 patients (45%), we found deletions of p15/p16/p14, which were homozygous in 27 and hemizygous in 14. Cytogenetic analysis demonstrated abnormalities of the short arm of chromosome 9 in the form of 9p- or del(9p21-22) in only 5 of the 41 patients (12%). Only 2 of 51 patients without gene deletions as detected by Southern blot revealed a 9p- abnormality, which was found only in a subpopulation of the cells. We demonstrate that deletions of the p15/p16/p14 genes on chromosome 9p21 are more frequent than indicated by cytogenetic analysis. Molecular techniques in addition to cytogenetic studies are necessary to detect otherwise-unrecognized genetic lesions of the short arm of chromosome 9.

AB - Cytogenetic changes are of pivotal prognostic significance in patients with de novo acute lymphoblastic leukemia (ALL). However, in some cases leukemic blasts can harbor gene lesions on a submicroscopic level without evidence of a corresponding abnormality by conventional cytogenetic studies. This can result in failure to recognize chromosomal abnormalities and inappropriate evaluation with respect to therapy assignments. To study the discrepancy in the detection of deletions of the short arm of chromosome 9 and deletions of tumor suppressor genes p15/p16/p14 on chromosome 9p21, we analyzed bone marrow samples from 92 patients with ALL both by cytogenetic analysis and by Southern blot. In 41 patients (45%), we found deletions of p15/p16/p14, which were homozygous in 27 and hemizygous in 14. Cytogenetic analysis demonstrated abnormalities of the short arm of chromosome 9 in the form of 9p- or del(9p21-22) in only 5 of the 41 patients (12%). Only 2 of 51 patients without gene deletions as detected by Southern blot revealed a 9p- abnormality, which was found only in a subpopulation of the cells. We demonstrate that deletions of the p15/p16/p14 genes on chromosome 9p21 are more frequent than indicated by cytogenetic analysis. Molecular techniques in addition to cytogenetic studies are necessary to detect otherwise-unrecognized genetic lesions of the short arm of chromosome 9.

KW - 9p21

KW - Acute lymphoblastic leukemia

KW - Cryptic abnormalities

KW - Cytogenetics

KW - Molecular abnormalities

KW - p15/p16/p14 deletion

UR - http://www.scopus.com/inward/record.url?scp=0032885986&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032885986&partnerID=8YFLogxK

M3 - Article

C2 - 10641574

AN - SCOPUS:0032885986

VL - 5

SP - 159

EP - 163

JO - Cytokines, Cellular and Molecular Therapy

JF - Cytokines, Cellular and Molecular Therapy

SN - 1368-4736

IS - 3

ER -